RHI MAGNESITA N.V.

(registered in the Netherlands with company number 68991665)

RESPONSE TO THE PARTIAL CASH OFFER

by

Ignite Luxembourg Holdings S.à r.l.

for

14,086,156 shares, representing 29.9 per cent. of the Issued and Outstanding Share Capital
of the Company

Shareholders should carefully read the whole of this document (including any information incorporated into this document by reference to another source). In particular, your attention is drawn to the letter from the Non-Executive Chairman which is set out below.

The Company is a public limited liability company incorporated under Dutch law, with its registered seat in Arnhem, the Netherlands. Therefore, the UK City Code on Takeovers and Mergers does not apply to the Offer and the Offer is not subject to the jurisdiction of, or being regulated by, the UK Panel on Takeovers and Mergers, and only section 27c of the Austrian Takeover Act ("ATA") is relevant to the Company. As the Offer is a voluntary public partial offer, pursuant to section 27c para 1 ATA, section 27c para 2 ATA does not apply to it and the Offer is not subject to the jurisdiction of, or being regulated by, the Austrian Takeover Commission. The shares in the Company, in the form of dematerialised depositary interests representing entitlements in the shares, are admitted to trading on the London Stock Exchange and the Vienna Stock Exchange (Wiener Börse).

Barclays Bank PLC, acting through its Investment Bank ("Barclays"), which is authorised by the PRA and regulated in the United Kingdom by the FCA and the PRA, is acting exclusively for RHI Magnesita and no one else in connection with the Offer and will not be responsible to any person other than RHI Magnesita for providing the protections afforded to the clients of Barclays nor for providing advice in relation to the Offer or any other matters referred to in this document.

Peel Hunt, which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively as financial adviser and corporate broker to RHI Magnesita and for no one else in connection with the matters referred to in this document and will not be responsible to any person other than RHI Magnesita for providing the protections afforded to clients of Peel Hunt, nor for providing advice in relation to the matters referred to herein. Neither Peel Hunt nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Peel Hunt in connection with the matters referred to in this document, or otherwise.

The date of publication of this document is 27 June 2023. All references to time in this document are references to Central European Time unless otherwise stated.

Letter from the Non-Executive Chairman of RHI Magnesita N.V.

(registered in the Netherlands with registered number 68991665)

Registered office Kranichberggasse 6, 1120 Vienna, Austria

27 June 2023

Dear Shareholder

Response of the Board to the Partial Cash Offer by Ignite Luxembourg Holdings S.à r.l. for 14,086,156 Shares, representing 29.9 per cent. of the Issued and Outstanding Share Capital of the Company

Terms of the Offer

On 30 May 2023, the Offeror announced its intention to make a voluntary partial cash offer to acquire 9,403,539 Shares, representing 20 per cent. of the Issued and Outstanding Share Capital of the Company (excluding treasury shares) at a price of GBP 28.50 for each Share (the "Offer Price"). The Offeror is a wholly-owned subsidiary of a number of limited partnerships which are indirectly managed by Rhône. The Offer does not relate to the acquisition of Shares held by the Company in treasury.

The Offer Document was published on 19 June 2023 detailing the Offeror's voluntary partial cash offer, and increasing the number of Shares the Offeror is seeking to acquire to up to 14,086,156 Shares (corresponding to 29.9% of the entire Issued and Outstanding Share Capital of the Company). The Offer Document states that the Offer Price will not be reduced in respect of the dividend of EUR 1.10 per Share declared by the Company on 24 May 2023 for the financial year ended 31 December 2022 (the "Declared Dividend"). The record date for the Declared Dividend was 9 June 2023 and the Declared Dividend is due to be paid by the Company on 6 July 2023. Should the Company, prior to the settlement of the Offer, announce, declare, make, pay or distribute dividends or any other distribution or transfer or return of value to its Shareholders other than the Declared Dividend, the Offeror has reserved the right to make an equivalent deduction to the consideration payable for the Shares in the Offer.

The Offer Price values RHI Magnesita's Issued and Outstanding Share Capital as at the date of this Response Statement at approximately GBP 1,340.0 million, or EUR 1,561.2 million at the Response Document Exchange Rate.

In case the total amount of Tendered Shares together with any Shares (the "Additional Shares") acquired by or on behalf of the Offeror outside of the Offer exceeds the amount of Offer Shares (i.e. 14,086,156, representing 29.9 per cent. of the Issued and Outstanding Share Capital as at the date of the Offer Document), all duly submitted acceptances will be scaled down pro rata to such number of Shares as shall not exceed the amount of Offer Shares less the Additional Shares. The total amount of Shares acquired by the Offeror under the Offer, together with any Additional Shares, shall not exceed 29.9 per cent. of the Company's Issued and Outstanding Share Capital.

The acceptance period commenced on 19 June 2023 and is expected to expire at 1:00pm London time on 10 July 2023. Acceptances of the Offer are irrevocable and cannot be withdrawn (including, without limitation, in the case of a Competing Offer or if the Offer is revised in accordance with the Offer Document or extended).

The Offeror has stated that, if the Offer is successful, the Offeror will seek appropriate representation in the board of directors of the Company. However, this is not a condition to completion of the Offer. No relationship agreement or any other governance arrangement has been agreed between the Offeror and the Company.

The Offer is conditional upon the conditions set out in section 4 of the Offer Document, including the receipt of approvals (or confirmation they do not have jurisdiction) from competition authorities in Austria, Germany, India and Mexico and the foreign investment authorities in Austria, France, Germany, Italy, Spain and the United Kingdom and such other competition or foreign investment authorities with respect to which the Offeror determines that the consent, approval, clearance, confirmation or licence thereof is required or advisable for the formation and funding of the Offeror or any other acquisition vehicle, or completion of the Offer under applicable competition or foreign investment laws (the "Competition and FDI Approvals"). If such conditions are not satisfied, or waived by the Offeror, the Offer may be withdrawn.

The Company's current trading and nancial position

As the Company announced on 15 June 2023, the momentum of improving protability and margins delivered in Q1 2023 continued in April and May, as refractory pricing was largely maintained against a background of reducing costs.

Refractory sales volumes in the five months ended 31 May 2023 (the "Period") excluding M&A were 7.0 per cent. lower year on year, in line with overall market demand. Steel, cement and glass demand outside of India remains soft due to a slowdown in construction activity, with some glass project postponements now evident. Demand in the non-ferrous metals segment continues to be resilient. As anticipated, due to the subdued demand backdrop and reducing input costs, the Group is beginning to experience sales price deation in a number of its markets which is expected to continue, and possibly accelerate, through the remainder of the year.

Refractory EBITA margin contribution for the Period, which excludes vertical integration benets, was better than expected, supported by cost deation in April and May, as the cost of freight and purchased raw material reduced, partially oset by weaker xed cost absorption due to lower production volumes.

The continued lower pricing environment for magnesite-based raw materials means that the Group's vertical integration EBITA margin contribution remains subdued and in line with the 1.8 per cent. of Group margin delivered in the second half of 2022.

As a result, the overall adjusted EBITA margin for the Period was 12.1 per cent. (2022: 11.6 per cent.), delivering unaudited adjusted EBITA of EUR 174 million (2022: EUR 155 million).

Net debt to EBITDA remains at a similar level to the 2.1x reported at 31 March 2023, including a 12 month historic contribution from businesses acquired during the period.

Absolute net debt at 31 May 2023 was largely unchanged from 31 December 2022, supported by strong operating cashflow. The Group continues to retain significant liquidity of EUR 1.2 billion.

Net working capital (before consolidation of M&A) was down slightly from its 31 December 2022 level, as reductions in inventory and accounts receivable were largely offset by lower accounts payable. The Group continues to prioritise security of supply for its customers in order to support recent market share gains.

Total capital expenditure in the five months to 31 May 2023 was EUR 42 million, out of overall guidance of EUR 200 million for 2023, with spending weighted towards the second half.

M&A increased net debt by EUR 268 million in the first five months of the year, which was partially offset by the Qualified Institutional Placement ("QIP") by RHI Magnesita India Ltd, which raised approximately EUR 101 million in April 2023. The QIP is to be followed by an equity investment of EUR 22 million by the Group in RHI Magnesita India Ltd via a preferential issue, which is expected to complete in June 2023. In the second half of the year, the previously announced acquisition of the European, Indian, and US-based operations of Seven Refractories for cash consideration of EUR 95 million is expected to be completed.

The outlook for the Group's key end markets, and consequently customer volumes, remains uncertain, with the order book currently suggesting only a moderate volume increase in H2, if at all, resulting in ongoing under-absorption of fixed costs. Pricing pressure is expected to continue and possibly accelerate through the remainder of the year.

Supported by the stronger than expected performance in the first five months of the year, the Board now expects a modest outperformance on its earlier 2023 EBITA and EBITA margin guidance.

Leverage, measured as a ratio of net debt to EBITDA, is expected to remain above 2.0x as the Group further executes on its M&A pipeline.

The Board's financial assessment of the Offer

The Board has reviewed a number of different reference points and applied a number of different valuation methodologies to underpin its financial assessment on the Offer (each of which is considered further below), including, amongst other things:

(i)           historical share price analysis;

(ii)          equity research analyst price targets;

(iii)         discounted cash flow analysis; and

(iv)         selected comparable company analysis.

The Board did not attribute any particular weight to any single analysis or factor considered by it but rather made qualitative judgments as to the significance and relevance of each analysis and factor relative to all other analyses and factors performed and considered by it and in the context of the circumstances of the Offer.

(i) Historical share price analysis

The Board analysed the historical trading prices of the Company's shares between 26 May 2018 and 26 May 2023, being the last Trading Day prior to the announcement of the Offer. During this period, the Company's average closing share price was GBP 33.70. The Board notes that the Offer Price of GBP 28.50 is below this five-year average share price (representing a 15.4 per cent. discount).

The Board notes that the Offer Price represents a premium of approximately 24.0 per cent. and 20.5 per cent. to the volume-weighted average trading prices of GBP 22.99 and GBP 23.65 during the last three months and six months prior to the announcement of the Offer.

(ii) Equity research analyst price targets

The Board also reviewed the price targets for the Company's shares published by seven equity research analysts as at 26 May 2023. The Offer Price is lower than the average target price of GBP 30.73 (representing a 7.3 per cent. discount) and the majority of equity research analysts (five out of seven) published a price target for the Company above the Offer Price.

(iii) Discounted cash flow analysis

In order to assess the fundamental, intrinsic value of the Company's shares, the Board performed a discounted cash flow analysis by calculating the present value of the Company's projected future cash flows based on Management's projections in their business plan and certain assumptions on the weighted cost of capital and perpetual growth rate. The discounted cash flow analysis produced a range of prices that were higher than the Offer Price.

As part of the Board's view on the fundamental value of the Offer, the Board has taken into account the future prospects of the business and delivery on its own strategy. The Board believes that the expectations reflected in the discounted cash flow analysis are based on reasonable assumptions. Nevertheless, no assurance can be given and no representations are made as to the accuracy and completeness of such analysis. Any forward-looking analysis must be considered with the fact that actual events or results may vary materially from such forward-looking statements due to, among other things, risks in executing the strategy, political, financial, economic, commercial or legal changes in the markets and environments in which RHI Magnesita does business, to competitive developments or risks inherent to the Company's business plans and to uncertainties, risk and volatility in financial markets and other factors affecting RHI Magnesita.

(iv) Selected comparable company analysis

The Board analysed the historical and current trading multiples (including, amongst other things, the current enterprise value compared to the estimated projected earnings before interest, tax and amortisation for the year ending 31 December 2023) of the Company as well as selected comparable listed companies and applied them to Management's projections to calculate a range of implied prices for the Company's shares, all of which were higher than the Offer Price.

The Board, having been so advised by Barclays and Peel Hunt on the financial terms of the offer, is of the view that the Offer undervalues the Company. In providing their financial advice to the Board, Barclays and Peel Hunt have taken into account the commercial assessments of the Board.

However, the Board recognises that the premium may be attractive to individual Shareholders who should form their own view independently with respect to the value of the Offer, taking into account their own individual investment considerations, their investment time horizons and the liquidity that may be provided by the Offer.

Regulatory status of the Offer

The Offer is not subject to the jurisdiction of, or being regulated by, the UK Panel on Takeovers and Mergers, the Austrian Takeover Commission or the Netherlands Decree on Public Takeover bids (save pursuant to article 20 and Annex G of the Netherlands Authority for the Financial Markets). As a result, the protections that are afforded to offeree company shareholders in relation to offers regulated by those authorities are not applicable to the Offer. If the Offeror were to make a general offer or mandatory offer for the Company in the future, such an offer would be regulated by the ATA.

Implications for control of the Company

The current free float (as defined in the Appendix) of the Company amounts to approximately 55.5 per cent., and approximately 11.8 per cent. of the Company's share capital is held by two institutional investment organisations. If the Offer is successful, the Offeror will hold at least 20 per cent. of the Company and, depending on which Shareholders tender their shares into the Offer, the free float could decrease to approximately 35.5 per cent. If the Offeror were to acquire 29.9 per cent. of the Company's shares, the free float could further decrease to approximately 25.6 per cent.  

As a consequence of this, the level of control that the Shareholders who form part of the free float currently have will be reduced, and they may have limited ability to influence the affairs of the Company by exercise of their voting rights. The Offeror and the Company's largest Shareholders may be able to exercise majority control over the Company on any individual matter. The Offer Document states that, if the Offer is successful, the Offeror will seek to achieve appropriate representation in the Board. The Board has not made any determination at this stage as to whether the Offeror will be granted any representation on the Board.

If the Offer is successful, it will be challenging for any potential bidder to successfully complete a full takeover of the Company in circumstances where the free float is between 36 per cent. and 26 per cent. and the existing major shareholders do not support the takeover offer, which means that minority shareholders are unlikely to have the opportunity to realise a control premium for their investment.

The reduction in the free float of the Company could also potentially translate into lower liquidity levels and reduction in daily trading volumes, which in turn could make it more difficult for new shareholders to invest in the Company and/or existing Shareholders to realise their investments in the Company. However, Shareholders should also take into account that, as is discussed further below, daily trading volumes in the Company's shares are already relatively low (average daily trading volume in the Company's shares for the three months ended 26 May 2023 was 47,198 shares which equates to approximately 0.1 per cent. of the total number of the Issued Share Capital), and the Offer therefore represents a significant liquidity opportunity for Shareholders who are seeking to monetise their investment in the Company.

The Offeror has noted in the Offer Document that if the Offer is successful there is a risk that the Company may no longer meet the eligibility requirements for inclusion in the FTSE 250 Index.

Features of the Offer and associated factors

In addition to the above, the Board would like to draw Shareholders' attention to the following when considering whether to accept the Offer:

1.         Premium over pre-announcement and recent share price performance - The Offer Price is at a c.39.0 per cent. premium to the closing price of the Company's shares of GBP 20.50 on 26 May, the last Trading Day prior to the announcement of the Offer. Similarly, in comparison to the volume weighted average share price for the last one, three, six and 12 months prior to the announcement of the Offer, the premium implied by the Offer amounts to 30.4 per cent., 24.0 per cent., 20.5 per cent. and 34.6 per cent. respectively. Shareholders who accept the Offer may be able to realise their investment in the Company at a premium to the pre-announcement share price and recent share price performance.

2.       Liquidity event for Shareholders - The average daily trading volume in the Company's shares for the three months ended 26 May 2023 is 47,198 shares. The number of Offer Shares equates to the aggregate trading volumes over a period of approximately 298 days. As such, the Offer represents a significant liquidity opportunity for Shareholders who are seeking to monetise their investment in the Company. This is especially relevant for Shareholders with larger shareholdings as any exit would need to be executed over an extended period of time, alongside the possibility of negative impact on the share price.

3.         Rhône has an established track record of investment in and supporting the strategy of the Company - Rhône had been a long-term investor in Magnesita Refratários S.A. ("Magnesita") (since its acquisition of LWB Refractories in 2007, which became part of the Magnesita group in 2008) and exited its investment in 2018 following the formation of the RHI Magnesita group of companies in 2017. During its tenure as a shareholder, Rhône was supportive of the management of Magnesita and its overall strategy. It understands the operations and key stakeholders of the business and, as the holder of a strategic minority stake, Rhône will have the opportunity to contribute its industry expertise and work alongside Management to deliver the next chapter of growth and value creation for the Company and its shareholders. Rhône has confirmed to the Board that it is supportive of the strategy to provide total heat management solutions with raw material backward integration and to grow through consolidation in the refractory industry with a focus on technology and sustainability leadership.

4.         Benefits of organic and inorganic growth initiatives not fully realised and reflected in current share price - The Company has relatively higher levels of financial leverage today compared to historical levels and comparable listed companies. This is the result of the structural build-up of inventories to better serve customers and both organic and inorganic growth initiatives through greater investment in the business and M&A activity. The benefits of these investments and acquisitions (including synergies) have yet to be fully realised, and the Board believes that these are not fully reflected in the current share price. Shareholders who accept the Offer may not benefit fully from the delivery of these benefits beyond the value of the Offer premium.

5.         No certainty as to when the Offer will complete - The Offer Document states that the acceptance period of the Offer is expected to expire at 1:00pm London Time on 10 July 2023 and that, subject to the conditions precedent being satisfied (or waived by the Offeror) by no later than 30 September 2023, settlement is expected to begin by no later than 13 October 2023. However, the Offeror has reserved the right to extend the acceptance period for the Offer to no later than the date falling one week after the Competition and FDI Approvals are satisfied (or waived by the Offeror). The Offer is not subject to any longstop date mechanism. Accordingly, there can be no certainty as to when the Offer will complete and Shareholders who do accept the Offer will have to wait until completion of the Offer until they receive the consideration due under the Offer (and during that time, as discussed further in paragraph 10 below, Shareholders who have accepted the Offer will not have the right to withdraw their acceptances under any circumstances). Should the Company, prior to the settlement of the Offer, announce, declare, make, pay or distribute dividends or any other distribution or transfer or return of value to its shareholders other than the Declared Dividend, the Offeror has reserved the right to make an equivalent deduction to the consideration payable for the Shares in the Offer.

6.         Offer conditional on the Offeror acquiring 20 per cent. - The Offer is conditional on the Offeror receiving valid acceptances to such an extent that the Offeror will become the owner of Shares representing at least 20 per cent. of the Issued and Outstanding Share Capital of the Company. In the event that the Offeror does not receive sufficient acceptances, it will have the right to invoke the condition and withdraw the Offer.

7.         The Offer is subject to a number of other significant conditions - The Offer is conditional on the conditions referred to in the Offer Document. In addition to the acceptance condition (see paragraph 6 above), the Offer is conditional on, amongst other things:

7.1    competition authorities in Austria, Germany, India and Mexico and the foreign investment authorities in Austria, France, Germany, Italy, Spain and the United Kingdom and any other competition or foreign investment authorities which the Offeror has determined are required or advisable for the formation and funding of the Offeror or any other acquisition vehicle, or completion of the Offer, having given their approval to the transaction or having confirmed that the transaction does not fall within the jurisdiction of the relevant authority;

7.2        general conditions that, amongst other things, there has been no material adverse effect on the Group or the business since the Accounts Date and no member of the Group having purchased or redeemed any of its own securities, reduced its share capital or transferred or sold Shares out of treasury;

7.3        general conditions that, since the Announcement Date, there has been no material adverse change in the financial markets or conditions in Austria, the United Kingdom, the Netherlands or internationally; outbreak or escalation of hostilities or suspension or material limitations of trading on the London Stock Exchange or the Vienna Stock Exchange (Wiener Börse) or any over-the-counter market;

7.4        no decrease as at the close of trading of more than 10 per cent.:

(a)        in the market price for the Shares on the London Stock Exchange or in the general level of market prices for equity securities in the FTSE 250 Index (measured from the close of trading on 26 May 2023); or

(b)        in the market price for the Shares on the Vienna Stock Exchange or in the general level of market prices for equity securities in the ATX Prime Index, measured from the close of trading on 29 May 2023,

in each case, which subsists compared to the relevant closing price for the Shares or general level of market prices for equity securities in the FTSE 250 Index or ATX Prime Index (as applicable) on three consecutive trading days;

7.5        no third party, such as a governmental entity or employee representative body, having taken or having given notice to take any action which would or might reasonably be expected to prohibit or hinder or delay the Offer.

Shareholders should note that there can be no certainty that the conditions will be satisfied or waived. Therefore, even if they accept the Offer, there is no certainty that they will receive any cash consideration.

8.         Ability of the Offeror to scale down acceptances - The Offeror is not obliged to accept any Tendered Shares to the extent that it would result in the Offeror holding more than the total number of Offer Shares. Therefore, if acceptance by the Offeror of all Shares validly tendered would result in the Offeror holding more Shares than the number of Offer Shares, the total number of Tendered Shares will be scaled down pro rata (with the effect that the total number of Shares held by the Offeror upon declaring the Offer unconditional shall be equal to the number of Offer Shares).

9.         Ability of the Offeror to acquire Shares outside of the Offer - The Offeror is not restricted under the Offer Document from acquiring additional Shares outside the Offer and, as a consequence of the Offer not being subject to the pricing provisions of the ATA, there are no restrictions on the minimum price that the Offeror must pay to Shareholders for Shares acquired outside of the Offer, nor any requirement to increase the Offer Price if Shares are purchased outside the Offer for a price above the Offer Price. The Offer Document contains a statement that the Offeror did not hold any securities in the Company as at the date of the Offer Document and that none of the Offeror's management, any entities controlled by the Offeror, any entities that control the Offeror or any of their affiliated persons hold securities in the Company.  

10.        Acceptance of the Offer will be irrevocable, including in the event of a Revised Offer - The Offer Document states that any acceptances of the Offer will be irrevocable. Shareholders should note therefore that, if they accept the Offer during the acceptance period, they will be unable to sell their Tendered Shares or accept another offer in respect of their Tendered Shares, including a higher Competing Offer, if one were to be made.  The Offeror has reserved the right to revise the Offer as may be necessary or desirable to give effect to any purported acceptance of the Offer and Shareholders who have accepted the Offer prior to the date of any revision will be bound by such revision, provided that it represents, as determined by the Offeror, an improvement (or no diminution) in the value of the Offer compared with the consideration or terms previously offered or in the overall value received and/or retained by a Shareholder (under the Offer or otherwise).

11.     The Offer is not available to all Shareholders - The Offer Document states that the communication of the Offer Document, and any other documents or materials relating to the Offer, is only being made to (i) persons who are outside the United Kingdom; (ii) investment professionals (as defined in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Financial Promotion Order")) or (iii) high net worth entities and other persons to whom it may lawfully be communicated, falling with Article 49(2)(a) to (d) of the Financial Promotion Order (all such persons together being referred to as "relevant persons"). Any investment activity to which the Offer Document relates will only be available to, and will only be engaged in, with relevant persons. Any person who is not a relevant person cannot act or rely on the Offer Document or any of its contents. In order to be eligible to view the Offer Document or make a decision with respect to the Offer, Shareholders must be outside the Restricted Jurisdictions and must not be a Restricted Person.

12.      Jurisdiction for disputes - any dispute regarding the Offer, or which arises in connection therewith, shall be exclusively settled by the courts of England and Wales, provided that under the Offer Document, the Offeror and the Receiving Agent (as defined in the Offer Document) have reserved the right to, and may in their absolute discretion, bring proceedings in the courts of any other country which may have jurisdiction.

13.        As at the date of this Response Statement, the Shareholders in the Company, who are defined as Insiders within the definition of 'free float' in the Appendix, have not publicly stated their views on the Offer.

Conclusion

The Board, having been so advised by Barclays and Peel Hunt on the financial terms of the offer, is of the view that the Offer undervalues the Company. In providing their financial advice to the Board, Barclays and Peel Hunt have taken into account the commercial assessments of the Board.

The Board believes that the benefits of organic and inorganic growth initiatives have not yet been fully realised or reflected in the share price. In addition, the Board notes that the Offer Price is lower than the average target price of equity research analysts of GBP 30.73 (representing a 7.3 per cent. discount) and the majority of equity research analysts (five out of seven) published a price target for the Company above the Offer Price.

The Offer is also subject to a number of significant conditions and there can be no certainty as to whether and, if it does, when the Offer will complete. Shareholders who accept the Offer will be unable to trade their Shares until the Offer is withdrawn or completes.

However, the Board notes that the Offer represents a premium over the pre-announcement share price and provides the possibility of a significant liquidity opportunity for Shareholders who are looking to monetise their investment given that the number of Offer Shares equates to the aggregate trading volumes over a period of approximately 298 days.

Taking into account the considerations set out above, the Board advises Shareholders to decide whether nor not to tender their Shares depending on their own individual investment considerations and their own individual circumstances.

The Board's views on the effect of the implementation of the Offer on the Company's interests, employees and locations

In addition to the matters set out above, article 20 and Annex G of the Netherlands Decree on Public Takeover bids requires the Board to give their views on certain matters, including the effect of the Offer on employment, the employment conditions and the locations of RHI Magnesita's places of business. In fullling these obligations under article 20 and Annex G of the Netherlands Decree on Public Takeover bids, the Board can only comment on the details provided in the Offer Announcement and the Offer Document.

The Board does not expect the Offer to have any negative impact on employment, employment conditions and the locations of RHI Magnesita's places of business. As mentioned above (see paragraph 3), Rhône was a long-term investor in Magnesita in the past and during its tenure as a shareholder, Rhône was supportive of Magnesita's management and their overall strategy.

Yours faithfully

Herbert Cordt

Non-Executive Chairman

RHI Magnesita N.V.